Rossari Biotech Limited (NSE:ROSSARI)

SolarWinds Revenue

Rossari Biotech had revenue of 5.44B INR in the quarter ending June 30, 2025, with 11.04% growth. This brings the company's revenue in the last twelve months to 21.34B, up 11.77% year-over-year. In the fiscal year ending March 31, 2025, Rossari Biotech had annual revenue of 20.80B with 13.64% growth.

• Revenue (ttm): 21.34B
• Revenue Growth: +11.77%
• P/S Ratio: 1.82
• Revenue / Employee: 39.89M
• Employees: 535
• Market Cap: 38.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	20.80B	2.50B	13.64%
Mar 31, 2024	18.31B	1.75B	10.55%
Mar 31, 2023	16.56B	1.73B	11.66%
Mar 31, 2022	14.83B	7.74B	109.06%
Mar 31, 2021	7.09B	1.09B	18.21%